185 related articles for article (PubMed ID: 37160771)
1. Characteristics and Management of Patients with Refractory or Unexplained Chronic Cough in Outpatient Hospital Clinics in Spain: A Retrospective Multicenter Study.
Dávila I; Puente L; Quirce S; Arismendi E; Díaz-Palacios M; Pereira-Vega A; de Diego A; Rodriguez-Hermosa JL; Cea-Calvo L; Sánchez-Jareño M; López-Cotarelo P; Domingo C
Lung; 2023 Jun; 201(3):275-286. PubMed ID: 37160771
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported experiences with refractory or unexplained chronic cough: a qualitative analysis.
Bali V; Schelfhout J; Sher MR; Tripathi Peters A; Patel GB; Mayorga M; Goss D; Romano CD
Ther Adv Respir Dis; 2024; 18():17534666241236025. PubMed ID: 38501735
[TBL] [Abstract][Full Text] [Related]
3. Determining What Represents Value in the Treatment of Refractory or Unexplained Chronic Cough from the Perspective of Key Stakeholders in Spain Using Multi-Criteria Decision Analysis.
Domingo C; Fernandez M; Garin N; Milara J; Moran I; Muerza I; Pacheco A; Teruel C; Bentley R; Subiran R; Gil A
Appl Health Econ Health Policy; 2023 Jan; 21(1):119-130. PubMed ID: 36319945
[TBL] [Abstract][Full Text] [Related]
4. [Chronic cough].
Kardos P
Pneumologie; 2023 Aug; 77(8):574-585. PubMed ID: 37619576
[TBL] [Abstract][Full Text] [Related]
5. A register-based study: cough - a frequent phenomenon in the adult population.
Backer V; Porsborg A; Hansen V; Skjold T; Schmid JM; Kehlet M; Torp-Pedersen C; Aasbjerg K
BMC Pulm Med; 2022 Nov; 22(1):426. PubMed ID: 36401236
[TBL] [Abstract][Full Text] [Related]
6. Understanding physician's knowledge and perception of chronic cough in Switzerland.
Leuppi JD; Guggisberg P; Koch D; Favre-Bulle A; Fabiani M; Heinz S; Zeller A
Curr Med Res Opin; 2022 Aug; 38(8):1459-1466. PubMed ID: 35369836
[TBL] [Abstract][Full Text] [Related]
7. Demographic, clinical, and patient-reported outcome data from 2 global, phase 3 trials of chronic cough.
Dicpinigaitis PV; Birring SS; Blaiss M; McGarvey LP; Morice AH; Pavord ID; Satia I; Smith JA; La Rosa C; Li Q; Nguyen AM; Schelfhout J; Tzontcheva A; Muccino D
Ann Allergy Asthma Immunol; 2023 Jan; 130(1):60-66. PubMed ID: 35569802
[TBL] [Abstract][Full Text] [Related]
8. Addressing unmet needs for diagnosis and management of chronic cough in the primary care setting.
Kardos P; Blaiss M; Dicpinigaitis P
Postgrad Med; 2021 Jun; 133(5):481-488. PubMed ID: 33830846
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant.
Morice AH; Birring SS; Smith JA; McGarvey LP; Schelfhout J; Martin Nguyen A; Xu ZJ; Wu WC; Muccino DR; Sher MR
Lung; 2021 Apr; 199(2):121-129. PubMed ID: 33825965
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Unexplained Chronic Cough: CHEST Guideline and Expert Panel Report.
Gibson P; Wang G; McGarvey L; Vertigan AE; Altman KW; Birring SS;
Chest; 2016 Jan; 149(1):27-44. PubMed ID: 26426314
[TBL] [Abstract][Full Text] [Related]
11. Antitussive efficacy of the current treatment protocol for refractory chronic cough: our real-world experience in a retrospective cohort study.
Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
Ther Adv Respir Dis; 2023; 17():17534666231167716. PubMed ID: 37078383
[TBL] [Abstract][Full Text] [Related]
12. New Insights Into Refractory Chronic Cough and Unexplained Chronic Cough: A 6-Year Ambispective Cohort Study.
Zhang M; Morice AH; Si F; Zhang L; Chen Q; Wang S; Zhu Y; Xu X; Yu L; Qiu Z
Allergy Asthma Immunol Res; 2023 Nov; 15(6):795-811. PubMed ID: 37957796
[TBL] [Abstract][Full Text] [Related]
13. A phase 3, randomized, double-blind, clinical study to evaluate the long-term safety and efficacy of gefapixant in Japanese adult participants with refractory or unexplained chronic cough.
Niimi A; Sagara H; Kikuchi M; Arano I; Sato A; Shirakawa M; La Rosa C; Muccino D
Allergol Int; 2022 Oct; 71(4):498-504. PubMed ID: 35752582
[TBL] [Abstract][Full Text] [Related]
14. Emerging drugs in the treatment of chronic cough.
Brister D; Wahab M; Rashad M; Diab N; Kolb M; Satia I
Expert Opin Emerg Drugs; 2023 Dec; 28(2):67-77. PubMed ID: 37060576
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms and Rationale for Targeted Therapies in Refractory and Unexplained Chronic Cough.
Mazzone SB; McGarvey L
Clin Pharmacol Ther; 2021 Mar; 109(3):619-636. PubMed ID: 32748976
[TBL] [Abstract][Full Text] [Related]
16. Speech and language therapy for management of chronic cough.
Slinger C; Mehdi SB; Milan SJ; Dodd S; Matthews J; Vyas A; Marsden PA
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD013067. PubMed ID: 31335963
[TBL] [Abstract][Full Text] [Related]
17. Can clinical characteristics differentiate patients with unexplained chronic cough from patients with asthma and COPD?
Singh U; Bernstein JA
Allergy Asthma Proc; 2023 Mar; 44(2):90-99. PubMed ID: 36872445
[No Abstract] [Full Text] [Related]
18. The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough.
de la Orden Abad M; Haberland C; Karn H; Skalicky A; Hareendran A
J Patient Rep Outcomes; 2023 Jul; 7(1):65. PubMed ID: 37428359
[TBL] [Abstract][Full Text] [Related]
19. Evaluation and Management Outcomes and Burdens in Patients with Refractory Chronic Cough Referred for Behavioral Cough Suppression Therapy.
Slovarp LJ; Jetté ME; Gillespie AI; Reynolds JE; Barkmeier-Kraemer JM
Lung; 2021 Jun; 199(3):263-271. PubMed ID: 33821355
[TBL] [Abstract][Full Text] [Related]
20. Burden of refractory and unexplained chronic cough on patients' lives: a cohort study.
Puente-Maestu L; Dávila I; Quirce S; Crespo-Lessmann A; Martínez-Moragón E; Sola J; Nieto ML; González-Barcala FJ; Cea-Calvo L; Sánchez-Jareño M; Rivas-Pardinas C; Domingo C
ERJ Open Res; 2023 Sep; 9(5):. PubMed ID: 37753282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
